(NYSE American: OGEN), a clinical-stage biotechnology company developing brain-targeted therapeutics through proprietary intranasal delivery technology, today announced that it has received final ...
Adelaide University had experienced an accreditation issue over human research. The newly merged institution said it received "conditional registration" for its Human Research Ethics Committees last ...
Bryet US Inc. has received Australian Human Research Ethics Committee (HREC) approval for its first-in-human study of ML-016 for patients with advanced cancer with lung and/or liver involvement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results